Molecular mechanism of manganese exposure-induced dopaminergic toxicity

@article{Prabhakaran2008MolecularMO,
  title={Molecular mechanism of manganese exposure-induced dopaminergic toxicity},
  author={K Prabhakaran and Debabrata Ghosh and Gail D. Chapman and Palur G. Gunasekar},
  journal={Brain Research Bulletin},
  year={2008},
  volume={76},
  pages={361-367}
}
View on Elsevier
doi.org
69 Citations
Background Citations
32
Methods Citations
2

Figures from this paper

69 Citations

BNIP3 up-regulation and mitochondrial dysfunction in manganese-induced neurotoxicity.
Manganese-exposed developing rats display motor deficits and striatal oxidative stress that are reversed by Trolox
TLDR
It is shown that long-term exposure to Mn during a critical period of neurodevelopment causes motor coordination dysfunction with parallel increment in oxidative stress markers, p38MAPK phosphorylation and caspase activity in the striatum and Trolox is established as a potential neuroprotective agent given its efficacy in reversing the Mn-induced neurodevelopmental effects.
α-Synuclein overexpression enhances manganese-induced neurotoxicity through the NF-κB-mediated pathway
TLDR
Assessment of the mechanism(s) of dopaminergic degeneration associated with α-synuclein expression in response to Mn exposure and the role of nuclear factor-κB activation as an intermediary of Mn-induced neurotoxicity indicate that the transcription factor NF-κBs, p38 MAPK, and apoptotic signaling cascades are activated by Mn in human α- synuclein-overexpressing cells.
In Vivo Manganese Exposure Modulates Erk, Akt and Darpp-32 in the Striatum of Developing Rats, and Impairs Their Motor Function
TLDR
Investigating the developmental neurotoxicity in an in vivo model of immature rats exposed to Mn from postnatal day 8 to PN12 establishes that short-term exposure to Mn during a specific developmental window induces metabolic and neurochemical alterations in the striatum that may modulate later-life behavioral changes.
α-Synuclein overexpression during manganese-induced apoptosis in SH-SY5Y neuroblastoma cells
Neurotoxicity mechanisms of manganese in the central nervous system.
Taurine Treatment Provides Neuroprotection in a Mouse Model of Manganism
TLDR
Taurine supplementation alleviated Mn-induced locomotor deficit and mitigated oxidative stress biomarkers and preserved brain tissue mitochondrial indices of functionality, introducing taurine as a potential neuroprotective agent against Mn neurotoxicity.
Extracellular Dopamine Potentiates Mn-Induced Oxidative Stress, Lifespan Reduction, and Dopaminergic Neurodegeneration in a BLI-3–Dependent Manner in Caenorhabditis elegans
TLDR
It is established that extracellular, and not intracellular, dopamine (DA) is responsible for Mn-induced DAergic neurodegeneration and that this process requires functional DA-reuptake transporter (DAT-1) and is associated with oxidative stress and lifespan reduction.
Manganese exposure is cytotoxic and alters dopaminergic and GABAergic neurons within the basal ganglia
TLDR
It is suggested that acute manganese exposure induces cytoskeletal dysfunction prior to degeneration and that chronic manganESE exposure results in neurochemical dysfunction with overlapping features to PD.
X-Ray Fluorescence Imaging: A New Tool for Studying Manganese Neurotoxicity
TLDR
X-ray fluorescence imaging is introduced as a new quantitative tool for analysis of the Mn distribution in the brain with high spatial resolution and can represent a link between Mn exposure and its potential effects for development of Parkinson's disease.
...
...

References

SHOWING 1-10 OF 61 REFERENCES
Enhancement of cytotoxicity and clastogenicity of l-DOPA and dopamine by manganese and copper.
Dopaminergic cell death induced by MPP+, oxidant and specific neurotoxicants shares the common molecular mechanism
TLDR
The high throughput cDNA microarray screening using the current model identified downstream response genes, such as heme oxygenase‐1, a constituent of Lewy bodies, that can be the useful biomarkers to monitor the pathological conditions of dopaminergic neurons under neurotoxic insult.
Cyanide enhancement of dopamine-induced apoptosis in mesencephalic cells involves mitochondrial dysfunction and oxidative stress.
Activation of early signaling transcription factor, NF-kappaB following low-level manganese exposure.
Deficiency of Inducible Nitric Oxide Synthase Protects Against MPTP Toxicity In Vivo
TLDR
It is suggested that iNOS‐derived nitric oxide produced in microglia plays an important role in the death of dopaminergic neurons but that other mechanisms contribute to the loss of dopamine terminals in MPTP neurotoxicity.
Manganese neurotoxicity: a focus on the neonate.
Mechanisms of the apoptotic and necrotic actions of trimethyltin in cerebellar granule cells.
TLDR
It was concluded that low concentrations of trimethyltin cause apoptotic cell death in which oxidative signaling is an important event, and higher concentrations of TMT initiate necrotic death, which involves both an oxidative and a non-oxidative component.
Selective vulnerability of glutathione metabolism and cellular defense mechanisms in rat striatum to manganese.
  • J. Liccione, M. Maines
  • Biology, Chemistry
    The Journal of pharmacology and experimental therapeutics
  • 1988
TLDR
Experimental evidence is provided for the hypothesis that compromised cellular defense mechanisms, i.e., glutathione (GSH), GSH-peroxidase and catalase in the brain may be involved in neuronal degeneration caused by manganese (Mn) neurotoxicity, and that the striatum is particularly susceptible to the deleterious effects of Mn.
Enhancing Effect of Manganese on L‐DOPA‐Induced Apoptosis in PC12 Cells
TLDR
The data show that agents that induce oxidative stress‐mediated apoptosis in catecholaminergic cells may act synergistically, and an increase in autoxidation of L‐DOPA and of newly formed DA is suggested as a mechanism of manganese action.
Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with IκBα induction and block of NFκB and iNOS activation
TLDR
The results suggest that pioglitazone sequentially acts through PPARγ activation, IκBα induction, block of NFκB activation, iNOS induction and NO‐mediated toxicity, and may offer a treatment opportunity in PD to slow the progression of disease that is mediated by inflammation.
...
...